Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Electrocardiographic and Echocardiographic Markers of Atrial and Ventricular Remodeling Allow Identification of Cardiac Sarcoidosis.

Created on 06 Nov 2026

Authors

Paula C Kuss, Björn C Frye, Sebastian Fähndrich, Iris Dvorak, Dirk Westermann, Heiko Lehrmann, Thomas Arentz, Daiana Stolz, Martin Eichenlaub

Published in

JACC. Clinical electrophysiology. Nov 05, 2026. Epub Nov 05, 2026.

Abstract

Cardiac sarcoidosis (CS) is a rare but life-threatening manifestation of systemic sarcoidosis. Although positron emission tomography-computed tomography (PET-CT) and cardiac magnetic resonance imaging provide high diagnostic accuracy, they are unsuitable for first-line screening. Widely available modalities such as electrocardiography (ECG) and transthoracic echocardiography (TTE) focusing only on ventricular abnormalities show limited sensitivity.
This study aims to evaluate whether a combined diagnostic model integrating ECG and TTE parameters, emphasizing atrial and ventricular remodeling, can accurately identify patients with CS.
We prospectively included 252 consecutive patients with biopsy-proven sarcoidosis. CS was defined by characteristic findings on PET-CT or cardiac magnetic resonance imaging. A comprehensive set of atrial and ventricular ECG and TTE parameters was analyzed. Diagnostic models were constructed using univariable and multivariable logistic regression, and discriminative performance was assessed.
CS was identified in 37 (14.7%) patients. On ECG, prolonged P-wave duration, prolonged QRS duration, and reduced T-wave amplitude in lead aVR were independently associated with CS. On TTE, increased left atrial volume index, increased left ventricular end-diastolic diameter, and impaired left ventricular global longitudinal strain emerged as significant predictors. ECG- and TTE-based models showed comparable discrimination for CS identification (area under the receiver operating characteristic curve: 0.87 for both). A combined ECG/TTE model, driven primarily by QRS duration, left atrial volume index, and left ventricular global longitudinal strain, achieved the highest diagnostic performance (area under the receiver operating characteristic curve: 0.90).
An exploratory multimodal, noninvasive approach integrating atrial and ventricular ECG and TTE markers provides high diagnostic accuracy for identifying CS and may serve as a pragmatic screening and triage tool to guide referral for advanced cardiac imaging. Clinical Trial Registration DRKS00031557 on drks.de (German Clinical Trials Register).

PMID:
42993131
Bibliographic data and abstract were imported from PubMed on 06 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement